Kenneth C. Frazier
2012
Compensation breakdown
Change in Pension Value and Nonqualified Deferred Compensation Earnings | $4,316,762 |
---|---|
Non-Equity Incentive Plan | $2,500,000 |
Option Awards | $3,799,998 |
Salary | $1,500,000 |
Stock Awards | $3,284,997 |
Other | $57,850 |
Total | $15,459,607 |
Frazier received $4.3M of change in pension value and nonqualified deferred compensation earnings, accounting for 28% of the total pay in 2012.
Frazier also received $2.5M in non-equity incentive plan, $3.8M in option awards, $1.5M in salary, $3.3M in stock awards and $57.9K in other compensation.
Rankings
In 2012, Kenneth C. Frazier's compensation ranked 172nd out of 11,487 executives tracked by ExecPay. In other words, Frazier earned more than 98.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 172 | 99th |
Manufacturing | 65 | 99th |
Chemicals And Allied Products | 13 | 99th |
Drugs | 8 | 99th |
Pharmaceutical Preparations | 7 | 99th |
Frazier's colleagues
We found five more compensation records of executives who worked with Kenneth C. Frazier at Merck & Co. in 2012.
2012
Adam Schechter
Merck & Co.
Executive Vice President and President, Global Human Health
2012
Peter Kim
Merck & Co.
Executive Vice President and President, Merck Research Laboratories
2012
Peter Kellogg
Merck & Co.
Chief Financial Officer
2012
Richard Bowles
Merck & Co.
Executive Vice President and Chief Ethics & Compliance Officer
2012
Bruce Kuhlik
Merck & Co.